$GEGR News! The Company is pleased to announce the
Post# of 115
(Total Views: 363)
Posted On: 03/22/2021 7:09:56 AM
$GEGR News! The Company is pleased to announce the first of at least 2 acquisitions in the Biotech Industry.
SSCB is a world renowned participant in Stem Cell Technology and places Gaensel in the front of this exciting and revolutionary health technology.
The Board expressed its pleasure working with the President Claudio Massa where he and his advisors have worked tirelessly over the past ninety days to ensure the success of the negotiations and final agreements being completed. The Shareholders of Gaensel will see the long term value this new partnership brings to the Company.
ABOUT SSCB
SSCB Swiss Stem Cells Biotech SA is a Biotech Company; SSCB was born in 2005 as a spin-off of Cardiocentro Ticino of Lugano - Switzerland and is also present with other offices in Italy, Spain, Albania and Balkan countries.
SSCB was founded as a private bank for the cryopreservation of human stem cells obtained from blood and cord tissue for both autologous and allogeneic intra-family use.
SSCB also allows the preservation of stem cells from adipose tissue. These cells have great potential in regenerative medicine, thanks to their ability to differentiate into numerous cell types and thus reconstruct many compromised tissues and organs.
SSCB operates in the field of cellular therapies with specialization in the collection, purification, characterization, processing and storage of stem cells for therapeutic and aesthetic uses and for the development of new experimental protocols.
https://finance.yahoo.com/news/gaensel-energy...00333.html
SSCB is a world renowned participant in Stem Cell Technology and places Gaensel in the front of this exciting and revolutionary health technology.
The Board expressed its pleasure working with the President Claudio Massa where he and his advisors have worked tirelessly over the past ninety days to ensure the success of the negotiations and final agreements being completed. The Shareholders of Gaensel will see the long term value this new partnership brings to the Company.
ABOUT SSCB
SSCB Swiss Stem Cells Biotech SA is a Biotech Company; SSCB was born in 2005 as a spin-off of Cardiocentro Ticino of Lugano - Switzerland and is also present with other offices in Italy, Spain, Albania and Balkan countries.
SSCB was founded as a private bank for the cryopreservation of human stem cells obtained from blood and cord tissue for both autologous and allogeneic intra-family use.
SSCB also allows the preservation of stem cells from adipose tissue. These cells have great potential in regenerative medicine, thanks to their ability to differentiate into numerous cell types and thus reconstruct many compromised tissues and organs.
SSCB operates in the field of cellular therapies with specialization in the collection, purification, characterization, processing and storage of stem cells for therapeutic and aesthetic uses and for the development of new experimental protocols.
https://finance.yahoo.com/news/gaensel-energy...00333.html
(0)
(0)